Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download…
Investing
-
-
Investing
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
by adminCardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview…
-
The US Federal Reserve announced an interest rate cut of 25 basis points on Wednesday (December…
-
Cyprium Metals Limited (ASX: CYM, OTC: CYPMF) (Cyprium or the Company) is pleased to announce the…
-
After trending down in 2023, nickel prices climbed to a 10 month high in late May…
-
E-Power Resources Inc (CSE: EPR) (FSE: 8RO) (‘E-Power‘ or the ‘Company’) announces its intention to complete…
-
Investing
Opawica Explorations: Advancing High-potential Gold Assets in the Prolific Abitibi Greenstone Belt
by adminOpawica Exploration (TSXV:OPW) is a Vancouver-based junior exploration company exploring and developing precious metal properties in…
-
(TheNewswire) TheNewswire – Troy Minerals Inc. (‘ Troy ‘ or the ‘ Company ‘ ) (CSE:…
-
The uranium market entered 2024 on strong footing after a year of significant price movement, as…
-
Mines and Money Miami, a key event for the mining industry, will take place on February…